BCM
AGN

Brookstone Capital Management’s Allergan plc AGN Stock Holding History

Brookstone Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-98
Closed -$27K – 986
2015
Q3 		$27K Sell
98
-5
-5% -$1.54K ﹤0.01% 632
2015
Q2 		$31K Buy
+103
New +$30.7K ﹤0.01% 654

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Brookstone Capital Management's AGN Position: Q4 2015 in Review

Brookstone Capital Management sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 98 shares — an estimated $27K sold.

Brookstone Capital Management first reported a position in AGN in Q2 2015 and held it in 2 quarters. The position peaked at $31K in Q2 2015. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Brookstone Capital Management reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
  • Brookstone Capital Management sold 98 Allergan plc shares in Q4 2015, an estimated $27K.
  • Brookstone Capital Management first reported a position in Allergan plc in Q2 2015 and held it in 2 quarters.
  • Brookstone Capital Management's Allergan plc position peaked at $31K in Q2 2015.
  • 1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Brookstone Capital Management's 13F filing for Q4 2015, filed 14 Jan 2016.